Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	regulation of organelle organization	LIMA1 ACD IQGAP2 CALR SYNE1 SPTA1 SPTAN1 SPTBN1 TOM1 OBSL1 APOA1 TBC1D25 DZIP1 GBA2 MFN1 ARHGEF10L NRP1 TAOK2 TGFB2 ALMS1 DDHD1 SYNE2 BUB1B CEP135 FNIP1 MPHOSPH8 CAPRIN1 RAB5A	1.67e-06	1342	161	28	GO:0033043
GeneOntologyBiologicalProcess	regulation of actin filament-based process	LIMA1 IQGAP2 SPTA1 SPTAN1 SPTBN1 CASQ2 APOA1 GBA2 ARHGEF10L NRP1 TAOK2 TGFB2 ALMS1	4.14e-05	438	161	13	GO:0032970
GeneOntologyBiologicalProcess	regulation of actin cytoskeleton organization	LIMA1 IQGAP2 SPTA1 SPTAN1 SPTBN1 APOA1 GBA2 ARHGEF10L NRP1 TAOK2 TGFB2 ALMS1	5.04e-05	384	161	12	GO:0032956
GeneOntologyBiologicalProcess	positive regulation of cellular component organization	NPHP1 ARHGAP32 ACD CALR HOPX SYNE1 TOM1 OBSL1 APOA1 DZIP1 GDF2 MFN1 ARHGEF10L PTK7 NRP1 TGFB2 ALMS1 PTPRZ1 DDHD1 CEP135 FNIP1 MACF1 MPHOSPH8 CAPRIN1 NIN	5.83e-05	1366	161	25	GO:0051130
GeneOntologyCellularComponent	spectrin	SPTA1 SPTAN1 SPTBN1	3.64e-05	9	161	3	GO:0008091
GeneOntologyCellularComponent	ciliary transition fiber	DZIP1 CEP164 NIN	5.17e-05	10	161	3	GO:0097539
GeneOntologyCellularComponent	cuticular plate	SPTA1 SPTAN1 SPTBN1	1.21e-04	13	161	3	GO:0032437
GeneOntologyCellularComponent	cell leading edge	LIMA1 PDE4A IQGAP2 SPTBN1 ADGRV1 PTPRZ1 SYNE2 MACF1 RIPOR1 CTNNA1 KDF1 CAPRIN1 RAB5A	1.37e-04	500	161	13	GO:0031252
GeneOntologyCellularComponent	centriole	DZIP1 CNTLN CEP164 ALMS1 CEP135 KIF2A NIN	3.81e-04	172	161	7	GO:0005814
Domain	Spectrin_repeat	SYNE1 SPTA1 SPTAN1 SPTBN1 EVPL SYNE2 MACF1	3.31e-09	29	156	7	IPR002017
Domain	SPEC	SYNE1 SPTA1 SPTAN1 SPTBN1 EVPL SYNE2 MACF1	7.00e-09	32	156	7	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 SPTA1 SPTAN1 SPTBN1 EVPL SYNE2 MACF1	7.00e-09	32	156	7	IPR018159
Domain	Spectrin	SYNE1 SPTA1 SPTAN1 SPTBN1 SYNE2 MACF1	2.77e-08	23	156	6	PF00435
Domain	ACTININ_2	SYNE1 SPTBN1 SYNE2 MACF1	3.66e-05	23	156	4	PS00020
Domain	ACTININ_1	SYNE1 SPTBN1 SYNE2 MACF1	3.66e-05	23	156	4	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 SPTBN1 SYNE2 MACF1	3.66e-05	23	156	4	IPR001589
Domain	PL48	RIPOR3 RIPOR1	2.07e-04	3	156	2	PF15903
Domain	FAM65_N	RIPOR3 RIPOR1	2.07e-04	3	156	2	IPR031780
Domain	FAM65	RIPOR3 RIPOR1	2.07e-04	3	156	2	IPR026136
Domain	CH	IQGAP2 SYNE1 SPTBN1 SYNE2 MACF1	2.10e-04	65	156	5	SM00033
Domain	CH	IQGAP2 SYNE1 SPTBN1 SYNE2 MACF1	2.98e-04	70	156	5	PF00307
Domain	-	IQGAP2 SYNE1 SPTBN1 SYNE2 MACF1	3.18e-04	71	156	5	1.10.418.10
Domain	CH	IQGAP2 SYNE1 SPTBN1 SYNE2 MACF1	3.62e-04	73	156	5	PS50021
Domain	CH-domain	IQGAP2 SYNE1 SPTBN1 SYNE2 MACF1	4.11e-04	75	156	5	IPR001715
Domain	KASH	SYNE1 SYNE2	4.11e-04	4	156	2	IPR012315
Domain	KASH	SYNE1 SYNE2	4.11e-04	4	156	2	PS51049
Domain	KASH	SYNE1 SYNE2	4.11e-04	4	156	2	SM01249
Domain	KASH	SYNE1 SYNE2	4.11e-04	4	156	2	PF10541
Domain	Multidrug-R_assoc	ABCC3 ABCC1	4.11e-04	4	156	2	IPR005292
Domain	-	EVPL MACF1	1.02e-03	6	156	2	3.90.1290.10
Domain	EFhand_Ca_insen	SPTA1 SPTAN1	1.02e-03	6	156	2	PF08726
Domain	EF-hand_Ca_insen	SPTA1 SPTAN1	1.02e-03	6	156	2	IPR014837
Pathway	KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION	RAB5A RAB5B RAB5C	3.87e-05	8	127	3	M47778
Pathway	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	SPTA1 SPTAN1 SPTBN1	8.18e-05	10	127	3	MM15112
Pathway	REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS	CALR APOA1 APOB	1.12e-04	11	127	3	MM14926
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	UTP6 SART3 NUP107 TCOF1 CALR SPTAN1 SPTBN1 RBM39 BLM SART1 GTF3C1 TSR1 SYNE2 KMT2A HELZ MACF1 UTP20 CTNNA1 PLOD1 CAPRIN1 TP53BP1 USP47	5.15e-13	653	162	22	22586326
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SART3 ILF3 PDE7A NUP107 TCOF1 VWA8 CALR SYNE1 SPTAN1 SPTBN1 GNB1L OBSL1 NAP1L4 DZIP1 ANKLE2 PTK7 BLM TSR1 VANGL1 SYNE2 NECTIN2 BUB1B SUPT16H MACF1 CTNNA1 PLOD1 CAPRIN1 TP53BP1 STOM NIN	1.13e-11	1487	162	30	33957083
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	SART3 ILF3 NUP107 CALR COG7 SYNE1 PPP1R12B NAP1L4 APOA1 RBM39 BLM SART1 GTF3C1 PHF20L1 TSR1 EIF4B BUB1B CEP135 CTNNA1 PLOD1 CAPRIN1 RAB5C TP53BP1 USP47 STOM MYBL1	3.02e-11	1155	162	26	20360068
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ABCC1 ARHGAP32 NUP107 CALR PPP1R12B SPTAN1 SPTBN1 ANKLE2 BLM PTPRH TSR1 PTPRZ1 VANGL1 SYNE2 NECTIN2 LTN1 SUPT16H CEP135 TNRC6A HELZ CTNNA1 HERC1 PLOD1 NIN	1.36e-10	1049	162	24	27880917
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SART3 ILF3 IQGAP2 TCOF1 VWA8 SPTAN1 SPTBN1 OBSL1 APOA1 APOB THOC3 NRP1 TAOK2 TGM2 TSR1 SUPT16H TNRC6A KMT2A SMN1 PLOD1 CAPRIN1 RAB5A RAB5B RAB5C STOM MAJIN	1.18e-09	1371	162	26	36244648
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	UTP6 LIMA1 ILF3 NUP107 TCOF1 CALR SYNE1 OBSL1 RBM39 NRP1 SART1 GTF3C1 VANGL1 SYNE2 SUPT16H MACF1 UTP20 KIF2A CTNNA1 PLOD1 RAB5B RAB5C	2.73e-09	1024	162	22	24711643
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	UTP6 SART3 ILF3 NUP107 TCOF1 SCYL1 TAOK2 SART1 GTF3C1 SUPT16H KMT2A SMN1 TP53BP1	8.62e-09	341	162	13	32971831
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	DCHS2 NWD1 SPTBN1 MON1A THOC3 RBM39 BLM SART1 GTF3C1 EIF4B KMT2A KIF2A CTNNA1 HERC1 PLOD1	1.37e-08	497	162	15	36774506
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	DNHD1 LIMA1 ILF3 SYNE1 RBM39 LPIN3 SUPT16H MACF1 HERC1 DNAH5 PRDM16	1.48e-08	234	162	11	36243803
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SART3 LIMA1 ERCC5 ILF3 IQGAP2 SYNE1 SPTA1 PPP1R12B SPTAN1 SPTBN1 BIVM APOB ANKLE2 PTK7 SART1 MIA2 GTF3C1 PHF20L1 COG1 EIF4B SYNE2 SUPT16H KMT2A MACF1 MPHOSPH8	1.52e-08	1442	162	25	35575683
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	ABCC1 NUP107 TCOF1 VWA8 SYNE1 SPTAN1 SPTBN1 SCYL1 P4HA3 APOB TXNRD2 SART1 COG1 EIF4B SYNE2 RIPOR1 PLOD1 RAB5C	1.73e-08	754	162	18	35906200
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SART3 ILF3 NUP107 TCOF1 HECTD4 RBM39 BLM GTF3C1 SUPT16H SMN1 KIF2A PLOD1 CAPRIN1 TP53BP1	2.21e-08	440	162	14	34244565
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	LIMA1 ERCC5 ILF3 TCOF1 SPTAN1 SPTBN1 BLM SART1 GTF3C1 EIF4B KMT2A HELZ UTP20 RIPOR1 CTNNA1 TP53BP1 USP47 MOCOS	2.57e-08	774	162	18	15302935
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ARHGAP32 LIMA1 PDE4A ILF3 NRCAM IQGAP2 TCOF1 SYNE1 SPTAN1 SPTBN1 HECTD4 TAOK2 SART1 SYNE2 SUPT16H MACF1 KIF2A CTNNA1 CAPRIN1 TP53BP1	2.66e-08	963	162	20	28671696
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	SART3 LIMA1 ILF3 SPTAN1 SPTBN1 SCYL1 RBM39 SART1 TNRC6A CTNNA1 CAPRIN1	7.42e-08	274	162	11	34244482
Pubmed	alpha -Catenin binds directly to spectrin and facilitates spectrin-membrane assembly in vivo.	SPTAN1 SPTBN1 CTNNA1	9.92e-08	3	162	3	11069925
Pubmed	Rab5 is necessary for the biogenesis of the endolysosomal system in vivo.	RAB5A RAB5B RAB5C	9.92e-08	3	162	3	22622570
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	LIMA1 ILF3 TCOF1 CALR SYNE1 PPP1R12B SPTAN1 SPTBN1 OBSL1 APOB RBM39 SART1 TSR1 EIF4B SUPT16H UTP20 KIF2A CTNNA1 CAPRIN1	1.08e-07	949	162	19	36574265
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SART3 SYNE1 PPP1R12B TOM1 NAP1L4 THOC3 CEP164 TAOK2 BLM TSR1 VANGL1 EIF4B LTN1 TNRC6A TMEM266 KMT2A HELZ MACF1 UTP20 SMN1 MPHOSPH8 KIF2A RAB5C STOM	1.30e-07	1497	162	24	31527615
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	UTP6 SART3 TCOF1 CALR OBSL1 NAP1L4 EVPL APOA1 PTK7 GTF3C1 PTPRH VANGL1 LTN1 HELZ CTNNA1 PLOD1 RAB5A RAB5C USP47	1.60e-07	974	162	19	28675297
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ILF3 TCOF1 VWA8 SYNE1 SPTAN1 SPTBN1 HECTD4 NAP1L4 THOC3 RBM39 BLM SART1 GTF3C1 TSR1 VCAN SUPT16H MACF1 MPHOSPH8 KIF2A PLOD1	1.75e-07	1082	162	20	38697112
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	UTP6 SART3 DNHD1 ILF3 NUP107 TCOF1 CALR SYNE1 SPTAN1 SPTBN1 GNB1L APOB THOC3 RBM39 SART1 GTF3C1 TSR1 SUPT16H UTP20 MPHOSPH8 KIF2A DNAH5 CAPRIN1	2.17e-07	1425	162	23	30948266
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	NPHP1 SART3 LIMA1 NUP107 IQGAP2 CALR SCYL1 OBSL1 TBC1D25 ANKLE2 BBS9 BLM LPIN3 SART1 DDHD1 NECTIN2 SUPT16H HELZ RIPOR1 CTNNA1 TP53BP1 STOM	2.41e-07	1321	162	22	27173435
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SART3 ABCC1 IQGAP2 VWA8 CALR COG7 SPTAN1 SPTBN1 TOM1 NAP1L4 HMGCR RBM39 GTF3C1 COG1 MICB SYNE2 BUB1B LTN1 SUPT16H KMT2A CTNNA1 PLOD1 CAPRIN1	2.61e-07	1440	162	23	30833792
Pubmed	A protein interaction landscape of breast cancer.	ABCC1 ILF3 TCOF1 VWA8 ERAP1 TOM1 APOA1 TGM2 MCM9 SUPT16H MACF1 CTNNA1 PLOD1 RAB5C STOM	3.20e-07	634	162	15	34591612
Pubmed	The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation.	SPTA1 SPTAN1 SPTBN1	3.95e-07	4	162	3	21566095
Pubmed	Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin.	SPTA1 SPTAN1 SPTBN1	3.95e-07	4	162	3	3862089
Pubmed	Cloning, expression analysis, and chromosomal localization of murine and human homologues of a Xenopus mix gene.	SPTA1 TGFB2 MIXL1	3.95e-07	4	162	3	11084649
Pubmed	Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site.	SPTA1 SPTAN1 SPTBN1	3.95e-07	4	162	3	12820899
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	UTP6 SART3 LIMA1 ILF3 SPTAN1 SPTBN1 EVPL THOC3 RBM39 SART1 TGM2 GTF3C1 TSR1 EIF4B SUPT16H UTP20 SMN1 KIF2A CTNNA1 CAPRIN1 RAB5C	4.42e-07	1257	162	21	36526897
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	SART3 LIMA1 ILF3 IQGAP2 TCOF1 ACAT2 CALR SPTAN1 SPTBN1 TOM1 NAP1L4 RBM39 GTF3C1 TSR1 EIF4B SUPT16H MACF1 SMN1 CAPRIN1 RAB5C	4.50e-07	1149	162	20	35446349
Pubmed	The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.	LIMA1 ERCC5 ILF3 SPTAN1 SPTBN1 RBM39 SMN1 CAPRIN1	4.80e-07	147	162	8	28977470
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARHGAP32 NUP107 NAP1L4 ANKLE2 ALMS1 VANGL1 TNRC6A HELZ MACF1 STOM	4.86e-07	263	162	10	34702444
Pubmed	Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.	ILF3 CALR SPTAN1 SPTBN1 NAP1L4 RBM39 SUPT16H PLOD1 CAPRIN1	5.82e-07	206	162	9	22174317
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	SART3 ILF3 NUP107 TCOF1 SPTAN1 SPTBN1 BLM ALMS1 SUPT16H TNRC6A CTNNA1 CAPRIN1 TP53BP1	6.22e-07	494	162	13	26831064
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	LIMA1 ILF3 TCOF1 SPTAN1 SPTBN1 RBM39 BLM ESRP2 TSR1 CAPRIN1 RAB5C	6.38e-07	340	162	11	24332808
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	FLT4 TCOF1 SCYL1 APOB GRIK4 RBM39 PTK7 PTPRH MICB EIF4B HERC1 CAPRIN1	7.25e-07	420	162	12	28065597
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	SART3 ERCC5 ILF3 TCOF1 VWA8 SPTAN1 SPTBN1 GNB1L NAP1L4 RBM39 SART1 MIA2 TSR1 EIF4B SYNE2 SUPT16H MACF1 KIF2A CTNNA1 PLOD1 CAPRIN1 RAB5C	7.63e-07	1415	162	22	28515276
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ABCC3 ABCC1 ERAP1 CALR P4HA3 HMGCR PTK7 NRP1 TGFB2 TGM2 MIA2 GTF3C1 NECTIN2 LTN1 UTP20 KIF2A CTNNA1 PLOD1 RAB5C STOM	8.93e-07	1201	162	20	35696571
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SART3 ARHGAP32 LIMA1 ILF3 NRCAM IQGAP2 SYNE1 SPTA1 PPP1R12B SPTAN1 SPTBN1 TOM1 RBM39 PTPRZ1 VCAN EIF4B KMT2A MACF1 KIF2A CTNNA1 CAPRIN1 RAB5C	9.19e-07	1431	162	22	37142655
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	ILF3 TCOF1 RBM39 BLM SART1 GTF3C1 TSR1 EIF4B SUPT16H UTP20 MPHOSPH8 KIF2A PLOD1 CAPRIN1 RAB5A RAB5B RAB5C TP53BP1	9.40e-07	989	162	18	36424410
Pubmed	Large-scale profiling of Rab GTPase trafficking networks: the membrome.	RAB5A RAB5B RAB5C	9.85e-07	5	162	3	15944222
Pubmed	A growth factor signaling cascade confined to circular ruffles in macrophages.	RAB5A RAB5B RAB5C	9.85e-07	5	162	3	23213469
Pubmed	A novel binding protein composed of homophilic tetramer exhibits unique properties for the small GTPase Rab5.	RAB5A RAB5B RAB5C	9.85e-07	5	162	3	11733506
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	LIMA1 NUP107 TCOF1 SPTAN1 SPTBN1 SCYL1 EVPL SART1 MACF1 CTNNA1 TP53BP1	1.11e-06	360	162	11	33111431
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	SART3 RNASEH2A ACAT2 CALR COG7 SPTAN1 SPTBN1 TOM1 SCYL1 NAP1L4 TGM2 RNF123 TSR1 EIF4B BUB1B SUPT16H MACF1 RIPOR1 CTNNA1 HERC1 PLOD1 USP47	1.21e-06	1455	162	22	22863883
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ERAP1 SYNE1 OBSL1 ADGRV1 ALMS1 SYNE2 MACF1 PRDM16 NIN	1.21e-06	225	162	9	12168954
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	UTP6 SART3 ILF3 NUP107 ACAT2 SPTAN1 SPTBN1 ARMCX1 RBM39 BLM SART1 TGM2 GTF3C1 LTN1 SUPT16H MACF1 UTP20 KIF2A PLOD1 CAPRIN1 TP53BP1	1.43e-06	1353	162	21	29467282
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	ILF3 NUP107 VWA8 SYNE1 SCYL1 OBSL1 ANKLE2 RBM39 MFN1 BLM MIA2 ALMS1 VANGL1 SYNE2 SUPT16H KIF2A HERC1 PLOD1 CAPRIN1 RAB5C USP47 STOM	1.90e-06	1496	162	22	32877691
Pubmed	Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression.	APOA1 APOB HMGCR	1.96e-06	6	162	3	1352323
Pubmed	RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway.	RAB5A RAB5B RAB5C	1.96e-06	6	162	3	12972505
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	RNASEH2A SPTAN1 SCYL1 OBSL1 HMGCR ALMS1 LTN1 TNRC6A CAPRIN1	2.21e-06	242	162	9	34011540
Pubmed	Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event.	LIMA1 ILF3 TCOF1 SPTAN1 SPTBN1 SART1 EIF4B SUPT16H	2.40e-06	182	162	8	26527279
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SART3 OBSL1 PTK7 NRP1 LPIN3 TGM2 GTF3C1 TSR1 DDHD1 BUB1B KMT2A HELZ KIF2A MOCOS	2.41e-06	650	162	14	38777146
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	SART3 ARHGAP32 NRCAM VWA8 TAOK2 ALMS1 MACF1	2.73e-06	130	162	7	12421765
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	UTP6 LIMA1 ILF3 NUP107 SPTAN1 SPTBN1 THOC3 SART1 TGM2 SUPT16H MACF1 KIF2A PLOD1 CAPRIN1	2.87e-06	660	162	14	32780723
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	DNHD1 SYNE1 SPTA1 SPTAN1 ALMS1 EIF4B SYNE2 HELZ	2.93e-06	187	162	8	26460568
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGAP32 LIMA1 SPTAN1 SPTBN1 DZIP1 LPIN3 ALMS1 EIF4B SYNE2 NECTIN2 BUB1B KMT2A FNIP1 HELZ MACF1 KIF2A	3.01e-06	861	162	16	36931259
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	LIMA1 ILF3 CALR SYNE1 PPP1R12B CNTLN ANKLE2 PTK7 PTPRH VANGL1 SMN1 HERC1 CAPRIN1	3.19e-06	573	162	13	28330616
Pubmed	TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1/POT1 repressor of ATR signaling.	ACD BLM TP53BP1	3.42e-06	7	162	3	25344324
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NUP107 TCOF1 RNASEH2A OBSL1 CNTLN THOC3 BLM ALMS1 TNRC6A HELZ MACF1 TP53BP1 NIN	4.22e-06	588	162	13	38580884
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	DNHD1 IQGAP2 SPTBN1 TOM1 EVPL APOA1 IRF6 ADGRV1 CNTLN GDF2 TGM2 RIPOR1 PLOD1 RAB5B RAB5C STOM UEVLD	5.85e-06	1016	162	17	19056867
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	SART3 ILF3 TCOF1 SYNE1 SPTBN1 RBM39 SART1 ESRP2 EIF4B SUPT16H TNRC6A HELZ MACF1 UTP20 CAPRIN1	6.20e-06	807	162	15	22681889
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SART3 ARHGAP32 NRCAM VWA8 SPTAN1 SPTBN1 NAP1L4 ANKLE2 RBM39 PTK7 TAOK2 EIF4B TNRC6A HELZ MACF1 KIF2A CAPRIN1 TP53BP1	6.70e-06	1139	162	18	36417873
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	SART3 ABCC1 ILF3 SPTAN1 SPTBN1 SART1 TSR1 SUPT16H KMT2A MACF1 CTNNA1 CAPRIN1 RAB5C STOM	6.71e-06	711	162	14	33022573
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	LIMA1 NUP107 NAP1L4 BLM KMT2A UTP20 SMN1 KIF2A	6.89e-06	210	162	8	16565220
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SART3 VWA8 HECTD4 DZIP1 ADGRV1 ANKLE2 ARHGEF10L TAOK2 TSR1 DDHD1 TNRC6A NIN	7.73e-06	529	162	12	14621295
Pubmed	Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.	NUP107 VANGL1 SYNE2 CEP135 SMN1 CAPRIN1	8.19e-06	101	162	6	26949739
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	LIMA1 PDE4A ILF3 IQGAP2 TCOF1 SPTAN1 SPTBN1 NAP1L4 TGM2 SUPT16H MPHOSPH8 KIF2A CAPRIN1	8.26e-06	626	162	13	33644029
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	UTP6 ABCC1 NUP107 TCOF1 TOM1 SCYL1 OBSL1 ANKLE2 PTK7 TAOK2 COG1 NECTIN2 UTP20 CTNNA1 PLOD1 STOM	9.28e-06	942	162	16	31073040
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	UTP6 SART3 ACAT2 TOM1 EVPL APOA1 CNTLN GTF3C1 TNRC6A HELZ KIF2A RAB5A STOM NIN	9.31e-06	732	162	14	34732716
Pubmed	Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.	ACAT2 APOA1 APOB HMGCR	9.84e-06	29	162	4	20167577
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	LIMA1 ACAT2 ERAP1 COG7 SPTAN1 SPTBN1 SCYL1 EVPL TAOK2 BLM GTF3C1 VCAN EIF4B TMEM266 HELZ ZCCHC7 RAB5C TP53BP1 STOM	1.02e-05	1293	162	19	15342556
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	LIMA1 TCOF1 ERAP1 CALR SPTAN1 TOM1 APOB SART1 TSR1 VANGL1 EIF4B SYNE2 MACF1 PLOD1 CAPRIN1 RAB5B RAB5C TP53BP1 STOM	1.07e-05	1297	162	19	33545068
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	SPTA1 SPTAN1 SPTBN1	1.16e-05	10	162	3	22159418
Pubmed	Interaction cloning and characterization of the cDNA encoding the human prenylated rab acceptor (PRA1).	RAB5A RAB5B RAB5C	1.16e-05	10	162	3	10329441
Pubmed	USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells.	SPTAN1 SPTBN1 NRP1	1.16e-05	10	162	3	36653359
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	ALMS1 EIF4B BUB1B TNRC6A FNIP1 CTNNA1 RAB5A USP47	1.18e-05	226	162	8	25900982
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ARHGAP32 NAP1L4 CNTLN ANKLE2 RBM39 CEP164 ALMS1 TSR1 EIF4B BUB1B CEP135 TNRC6A PLOD1 USP47 NIN	1.19e-05	853	162	15	28718761
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	ABCC1 LIMA1 ILF3 TCOF1 CALR SPTAN1 SPTBN1 TXNRD2 NECTIN2 PLOD1 CAPRIN1 RAB5A RAB5B RAB5C STOM	1.30e-05	859	162	15	31536960
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	UTP6 OBSL1 CEP164 ULK3 ALMS1 CEP135 TNRC6A PLOD1 UEVLD	1.32e-05	302	162	9	30561431
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	NUP107 OBSL1 NAP1L4 ARMCX1 GTF3C1 ALMS1 SUPT16H TNRC6A KMT2A CTNNA1 TP53BP1	1.37e-05	469	162	11	27634302
Pubmed	High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.	ABCC1 ARHGAP32 PTK7 NRP1 MIA2 SUSD5 NECTIN2 TNRC6A STOM	1.50e-05	307	162	9	37499664
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	LIMA1 TOM1 CEP164 PHF20L1 SYNE2 TNRC6A UEVLD	1.59e-05	170	162	7	23314748
Pubmed	Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors.	SPTBN1 NECTIN2 MACF1	1.59e-05	11	162	3	39256359
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	SART3 ERCC5 ILF3 TCOF1 SPTAN1 TOM1 HECTD4 RNF123 MACF1 HERC1 USP47	1.73e-05	481	162	11	28190767
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	SART3 SPTAN1 SPTBN1 NAP1L4 BLM SART1 GTF3C1 SUPT16H KMT2A TP53BP1	1.75e-05	394	162	10	27248496
Pubmed	alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus.	ERCC5 SPTA1 SPTAN1 XPA	1.89e-05	34	162	4	16889989
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	SART3 ERCC5 NAP1L4 MFN1 MIA2 GTF3C1 TSR1 VANGL1 CTNNA1 USP47	1.94e-05	399	162	10	37536630
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	NUP107 TCOF1 VWA8 RNASEH2A OBSL1 SART1 ALMS1 PRPF40B VANGL1 TAF7L LTN1 SUPT16H TNRC6A HELZ MACF1 PRDM16 NIN	1.96e-05	1116	162	17	31753913
Pubmed	Association of polymorphisms in apolipoprotein A1 and apolipoprotein B genes with lipid profile in Tamilian population.	APOA1 APOB	2.16e-05	2	162	2	19729689
Pubmed	Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.	CALR CASQ2	2.16e-05	2	162	2	17607358
Pubmed	Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study.	APOA1 APOB	2.16e-05	2	162	2	26363640
Pubmed	Apolipoprotein A-I/apolipoprotein B ratio and aggression in violent and nonviolent young adult males.	APOA1 APOB	2.16e-05	2	162	2	16455106
Pubmed	Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients.	APOA1 APOB	2.16e-05	2	162	2	29776362
Pubmed	Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.	APOA1 APOB	2.16e-05	2	162	2	15242863
Pubmed	Severe growth retardation and short life span of double-mutant mice lacking Xpa and exon 15 of Xpg.	ERCC5 XPA	2.16e-05	2	162	2	15661658
Pubmed	The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population.	APOA1 APOB	2.16e-05	2	162	2	20213498
Pubmed	A meta-analysis of Italian and Estonian individuals shows an effect of common variants in HMGCR on blood apoB levels.	APOB HMGCR	2.16e-05	2	162	2	30191727
Pubmed	ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.	APOA1 APOB	2.16e-05	2	162	2	29440006
Interaction	GJA1 interactions	ABCC1 ARHGAP32 SPTAN1 SPTBN1 SCYL1 APOA1 APOB DZIP1 ANKLE2 TGM2 COG1 VANGL1 MICB EIF4B SYNE2 NECTIN2 MACF1 RAB5A RAB5C STOM	4.05e-08	583	160	20	int:GJA1
Interaction	CIT interactions	UTP6 ARHGAP32 LIMA1 ILF3 NUP107 TCOF1 VWA8 CALR SYNE1 SPTAN1 SPTBN1 OBSL1 APOB ADGRV1 THOC3 RBM39 SART1 ALMS1 TSR1 SYNE2 SUPT16H KMT2A MACF1 UTP20 MPHOSPH8 KIF2A CTNNA1 HERC1 PLOD1 CAPRIN1 RAB5A NIN	1.06e-07	1450	160	32	int:CIT
Interaction	SIRT7 interactions	UTP6 SART3 NUP107 TCOF1 CALR SPTAN1 SPTBN1 RBM39 BLM SART1 GTF3C1 TSR1 SYNE2 KMT2A HELZ MACF1 UTP20 CTNNA1 PLOD1 CAPRIN1 TP53BP1 USP47	1.10e-07	744	160	22	int:SIRT7
Interaction	MEGF10 interactions	SART3 ARHGAP32 VWA8 TAOK2 RNF123 ALMS1	2.11e-07	33	160	6	int:MEGF10
Interaction	EIF3L interactions	SART3 CALR SCYL1 NAP1L4 RBM39 RNF123 VANGL1 EIF4B SUPT16H PRDM16 CAPRIN1 RAB5A	6.00e-07	244	160	12	int:EIF3L
Interaction	KIF20A interactions	LIMA1 ILF3 VWA8 SYNE1 SPTAN1 SPTBN1 HECTD4 NAP1L4 APOB HMGCR BLM SART1 MIA2 ALMS1 COG1 SYNE2 SUPT16H CEP135 TNRC6A HELZ MACF1 HERC1 CAPRIN1 STOM KLB	8.63e-07	1052	160	25	int:KIF20A
Interaction	LYN interactions	ABCC1 ARHGAP32 LIMA1 PDE4A IQGAP2 SPTAN1 SPTBN1 NAP1L4 DZIP1 PTK7 RNF123 SLC22A16 TSR1 VANGL1 NECTIN2 KMT2A MACF1 CTNNA1 ZCCHC7 RAB5C	1.16e-06	720	160	20	int:LYN
Interaction	OCLN interactions	ABCC1 ARHGAP32 IQGAP2 SPTAN1 SPTBN1 DZIP1 NRP1 GJB1 MIA2 VANGL1 MICB NECTIN2 MACF1 CTNNA1 RAB5A RAB5C	2.47e-06	500	160	16	int:OCLN
Interaction	SYNE3 interactions	ARHGAP32 NUP107 ERAP1 CALR ANKLE2 CEP164 TAOK2 MIA2 ALMS1 SYNE2 TNRC6A HELZ MACF1 PLOD1 NIN	2.68e-06	444	160	15	int:SYNE3
Interaction	LRRC7 interactions	SPTBN1 PTK7 TAOK2 RNF123 NECTIN2 MACF1	6.56e-06	58	160	6	int:LRRC7
Interaction	FBXO22 interactions	DCHS2 NWD1 SPTBN1 MON1A THOC3 RBM39 BLM SART1 GTF3C1 EIF4B KMT2A KIF2A CTNNA1 HERC1 PLOD1 TP53BP1	6.57e-06	540	160	16	int:FBXO22
Interaction	CSNK2A1 interactions	SART3 ABCC1 ERCC5 ILF3 TCOF1 ACAT2 SPTBN1 OBSL1 NAP1L4 P4HA3 CASQ2 RBM39 NRP1 LPIN3 TSR1 EIF4B SUPT16H KMT2A MACF1 CTNNA1 KDF1 PRDM16	7.03e-06	956	160	22	int:CSNK2A1
Interaction	SEC61B interactions	ABCC1 ARHGAP32 ILF3 NUP107 ERAP1 CALR SYNE1 APOB HMGCR ANKLE2 GBA2 PTK7 NRP1 TAOK2 VANGL1 SYNE2 LTN1 PLOD1 RAB5C	1.05e-05	763	160	19	int:SEC61B
Interaction	TNIK interactions	ARHGAP32 SYNE1 SPTAN1 SPTBN1 TAOK2 SART1 SYNE2 SUPT16H MACF1 KIF2A CTNNA1 CAPRIN1 TP53BP1	1.15e-05	381	160	13	int:TNIK
Interaction	HERC2 interactions	SPTBN1 HECTD4 OBSL1 XPA RBM39 BLM SYNE2 CEP135 MACF1 CTNNA1 HERC1 RAB5A RAB5B TP53BP1 NIN	1.20e-05	503	160	15	int:HERC2
Interaction	AFDN interactions	ARHGAP32 LIMA1 OBSL1 TBC1D25 TAOK2 VANGL1 NECTIN2 TNRC6A KMT2A MACF1 CTNNA1 NIN	1.47e-05	333	160	12	int:AFDN
Interaction	EIF3M interactions	SART3 ILF3 SCYL1 NAP1L4 RBM39 GTF3C1 EIF4B CAPRIN1 RAB5A	1.53e-05	182	160	9	int:EIF3M
Interaction	BRCA1 interactions	SART3 DNHD1 ABCC1 ERCC5 ILF3 ACD NUP107 TCOF1 RNASEH2A ERAP1 SPTAN1 SPTBN1 CNTLN THOC3 BLM TGM2 ALMS1 SUPT16H TNRC6A KIF2A CTNNA1 HERC1 CAPRIN1 RAB5C TP53BP1	1.75e-05	1249	160	25	int:BRCA1
Interaction	PCNT interactions	SYNE1 SPTAN1 SPTBN1 OBSL1 NAP1L4 ALMS1 CEP135 MACF1 TP53BP1 NIN	2.36e-05	241	160	10	int:PCNT
Interaction	NUP155 interactions	FLT4 NUP107 NBEAL1 SCYL1 OBSL1 ANKLE2 ALMS1 COG1 SYNE2 CEP135 TNRC6A HELZ CTNNA1 RAB5A	2.83e-05	477	160	14	int:NUP155
Interaction	UCN3 interactions	VWA8 ADGRV1 UCN3 HERC1	3.01e-05	23	160	4	int:UCN3
Interaction	MYH9 interactions	NPHP1 LIMA1 TCOF1 PPP1R12B SPTAN1 SPTBN1 CASQ2 APOB TGM2 RNF123 TSR1 EIF4B LTN1 MACF1 DNAH5 CAPRIN1 USP47 STOM	3.19e-05	754	160	18	int:MYH9
Interaction	OBSL1 interactions	UTP6 ARHGAP32 LIMA1 ILF3 NUP107 TCOF1 SYNE1 OBSL1 CASQ2 RBM39 SART1 GTF3C1 SYNE2 SUPT16H FNIP1 MACF1 UTP20 KIF2A CTNNA1 PLOD1	3.23e-05	902	160	20	int:OBSL1
Interaction	CUL7 interactions	ARHGAP32 LIMA1 ILF3 NUP107 TCOF1 CALR OBSL1 CASQ2 APOA1 APOB RBM39 SART1 SYNE2 SUPT16H MACF1 KIF2A CTNNA1 RAB5B RAB5C	4.28e-05	845	160	19	int:CUL7
Interaction	RHOJ interactions	UTP6 ABCC1 ARHGAP32 IQGAP2 SPTAN1 SPTBN1 OBSL1 PTK7 VANGL1 NECTIN2 SUPT16H MACF1 UTP20 CTNNA1 RAB5C STOM	4.58e-05	633	160	16	int:RHOJ
Interaction	RAB2A interactions	ABCC1 ILF3 SPTBN1 OBSL1 TBC1D25 RBM39 NRP1 VANGL1 SUSD5 NECTIN2 RAB5A RAB5B RAB5C STOM NIN	4.79e-05	567	160	15	int:RAB2A
Interaction	GLDC interactions	SART3 LIMA1 ILF3 SPTAN1 SPTBN1 SCYL1 RBM39 SART1 TNRC6A CTNNA1 CAPRIN1	5.32e-05	321	160	11	int:GLDC
Interaction	ABCA6 interactions	APOA1 ANKLE2 ABCA10	5.66e-05	10	160	3	int:ABCA6
Interaction	SNCA interactions	SART3 ILF3 NUP107 IQGAP2 SPTBN1 SCYL1 NAP1L4 APOA1 PTK7 VCAN EIF4B SYNE2 MACF1 KIF2A CTNNA1 RAB5A USP47	5.72e-05	716	160	17	int:SNCA
Interaction	VCP interactions	ABCC3 ABCC1 NUP107 IQGAP2 CALR SPTAN1 SPTBN1 TOM1 OBSL1 APOA1 APOB HMGCR ANKLE2 RBM39 BLM ULK3 GTF3C1 PTPRH TSR1 VANGL1 EIF4B SUPT16H CTNNA1 CAPRIN1 RAB5C TP53BP1	6.34e-05	1435	160	26	int:VCP
Interaction	ZYX interactions	ARHGAP32 IQGAP2 OBSL1 FBXO10 ALMS1 BUB1B TNRC6A HELZ MACF1 CTNNA1 RAB5A	6.64e-05	329	160	11	int:ZYX
Interaction	LGALS1 interactions	LIMA1 FLT4 NRCAM PTK7 PTPRZ1 VANGL1 SUSD5 VCAN SMN1 RAB5C STOM	7.20e-05	332	160	11	int:LGALS1
Interaction	RHOA interactions	ABCC1 ARHGAP32 LIMA1 ERAP1 SPTAN1 SPTBN1 RIPOR3 ANKLE2 NRP1 TGM2 RNF123 MIA2 VANGL1 SYNE2 NECTIN2 SUPT16H MACF1 UTP20 CTNNA1 PLOD1 RAB5B RAB5C STOM	7.57e-05	1199	160	23	int:RHOA
Interaction	ANK1 interactions	SPTA1 PPP1R12B SPTAN1 SPTBN1 RNF123	8.16e-05	56	160	5	int:ANK1
Interaction	CEP63 interactions	SYNE1 SPTAN1 SPTBN1 ALMS1 BUB1B CEP135 MACF1 NIN	9.38e-05	179	160	8	int:CEP63
Interaction	TNIP1 interactions	LIMA1 ILF3 TCOF1 CALR SYNE1 PPP1R12B SPTAN1 SPTBN1 OBSL1 APOB RBM39 NRP1 SART1 ULK3 TSR1 EIF4B SUPT16H CEP135 UTP20 KIF2A CTNNA1 CAPRIN1 UEVLD	9.46e-05	1217	160	23	int:TNIP1
Interaction	FLOT1 interactions	ABCC1 ARHGAP32 LIMA1 SPTAN1 SPTBN1 OBSL1 DZIP1 VANGL1 NECTIN2 MACF1 CTNNA1 RAB5C NIN	1.11e-04	475	160	13	int:FLOT1
Interaction	DNAJB3 interactions	UTP6 SCYL1 RBM39 FBXO10 CAPRIN1	1.14e-04	60	160	5	int:DNAJB3
Interaction	YWHAZ interactions	ARHGAP32 LIMA1 PDE7A NUP107 SPTA1 SPTAN1 SPTBN1 HECTD4 OBSL1 DZIP1 RBM39 LPIN3 ULK3 TGM2 EIF4B SYNE2 NECTIN2 KMT2A MACF1 KIF2A ZCCHC7 TP53BP1 USP47 NIN	1.18e-04	1319	160	24	int:YWHAZ
Interaction	DYRK1A interactions	DCHS2 ERCC5 NUP107 TCOF1 SPTAN1 SPTBN1 OBSL1 EVPL RBM39 LPIN3 TGM2 EIF4B BUB1B CTNNA1	1.34e-04	552	160	14	int:DYRK1A
Interaction	SOX2 interactions	UTP6 SART3 LIMA1 ILF3 ACAT2 CALR SPTAN1 SPTBN1 TOM1 NAP1L4 EVPL APOA1 CNTLN GTF3C1 PHF20L1 SUPT16H TNRC6A KMT2A HELZ MACF1 KIF2A CAPRIN1 RAB5A STOM NIN	1.44e-04	1422	160	25	int:SOX2
Interaction	FAM120C interactions	P4HA3 RBM39 ESRP2 RNF123 TNRC6A HELZ SMN1 CAPRIN1	1.47e-04	191	160	8	int:FAM120C
Interaction	HDLBP interactions	SART3 ILF3 TCOF1 COG7 SPTAN1 SPTBN1 OBSL1 THOC3 TGM2 TSR1 SUPT16H TNRC6A KMT2A SMN1 ZCCHC7 RAB5A USP47 STOM	1.58e-04	855	160	18	int:HDLBP
Interaction	CANX interactions	ABCC3 ABCC1 LIMA1 FLT4 NRCAM NUP107 CALR SPTAN1 OBSL1 APOB HMGCR ANKLE2 RBM39 PTK7 GJB1 RNF123 PTPRH NECTIN2 KIF2A HERC1 PLOD1 RAB5A RAB5C	1.60e-04	1261	160	23	int:CANX
Interaction	RNF43 interactions	ARHGAP32 ILF3 NUP107 NAP1L4 ANKLE2 ALMS1 VANGL1 CEP135 TNRC6A HELZ MACF1 STOM	1.61e-04	427	160	12	int:RNF43
Interaction	SAFB2 interactions	RNASEH2A BIVM OBSL1 APOA1 RBM39 NRP1 MPHOSPH8 PRDM16	1.69e-04	195	160	8	int:SAFB2
Interaction	EMD interactions	FLT4 NUP107 SYNE1 SPTA1 SPTAN1 SCYL1 OBSL1 ANKLE2 GBA2 TAOK2 RNF123 VANGL1 SYNE2 CEP135 TNRC6A RAB5A RAB5C	1.84e-04	789	160	17	int:EMD
Interaction	IFI16 interactions	UTP6 SART3 ILF3 NUP107 SYNE1 SPTAN1 RBM39 SART1 TSR1 EIF4B SUPT16H HELZ UTP20 MPHOSPH8 CAPRIN1 TP53BP1	1.85e-04	714	160	16	int:IFI16
Interaction	HSPA12B interactions	VWA8 SPTAN1 SPTBN1 VANGL1 BUB1B	1.92e-04	67	160	5	int:HSPA12B
Interaction	GAN interactions	DNHD1 SYNE1 SPTA1 SPTAN1 ALMS1 EIF4B SYNE2 HELZ PLOD1	1.95e-04	253	160	9	int:GAN
Interaction	SUZ12 interactions	LIMA1 ILF3 NUP107 CALR SYNE1 OBSL1 ARMCX1 RBM39 SART1 GTF3C1 ALMS1 TSR1 SUPT16H TNRC6A CTNNA1	1.96e-04	644	160	15	int:SUZ12
Interaction	C11orf52 interactions	ABCC1 ARHGAP32 IQGAP2 SPTAN1 SPTBN1 PTK7 VANGL1 NECTIN2 MACF1 CTNNA1	1.96e-04	311	160	10	int:C11orf52
Interaction	CSNK2A2 interactions	SART3 ERCC5 TCOF1 VWA8 NAP1L4 CASQ2 RBM39 NRP1 LPIN3 TGM2 GTF3C1 TSR1 SUPT16H KMT2A PRDM16 TP53BP1	1.97e-04	718	160	16	int:CSNK2A2
Interaction	RAB35 interactions	NPHP1 ABCC1 ARHGAP32 IQGAP2 SPTAN1 SPTBN1 DZIP1 ANKLE2 NRP1 VANGL1 SYNE2 NECTIN2 MACF1 CTNNA1	1.98e-04	573	160	14	int:RAB35
Interaction	NDC80 interactions	CNTLN FAM170A CEP164 SART1 ALMS1 SYNE2 BUB1B CEP135 HERC1 NIN	2.01e-04	312	160	10	int:NDC80
Interaction	USP39 interactions	SART3 TSR2 OBSL1 RBM39 SART1 RNF123 GTF3C1 SUPT16H	2.08e-04	201	160	8	int:USP39
Interaction	RND2 interactions	ABCC1 SPTAN1 SPTBN1 SCYL1 ANKLE2 VANGL1 SYNE2 NECTIN2 SUPT16H UTP20 USP47 STOM	2.12e-04	440	160	12	int:RND2
Interaction	PFN1 interactions	CALR SPTAN1 SPTBN1 OBSL1 RBM39 RASSF5 RNF123 ALMS1 COG1 SYNE2 MACF1 KIF2A TP53BP1	2.19e-04	509	160	13	int:PFN1
Interaction	HRAS interactions	ABCC3 ABCC1 CALR SPTA1 SPTAN1 SPTBN1 APOB PTK7 RASSF5 VANGL1 SUSD5 NECTIN2 CTNNA1 KDF1 RAB5A RAB5C	2.20e-04	725	160	16	int:HRAS
Interaction	CLTC interactions	NPHP1 LIMA1 SPTAN1 SPTBN1 TOM1 OBSL1 RBM39 TGM2 RNF123 TNRC6A HELZ HERC1 PRDM16 RAB5B STOM	2.35e-04	655	160	15	int:CLTC
Interaction	RHOC interactions	ABCC1 ARHGAP32 SPTBN1 RIPOR3 ANKLE2 VANGL1 SYNE2 NECTIN2 KMT2A MACF1 UTP20 CTNNA1 RAB5B STOM	2.40e-04	584	160	14	int:RHOC
Interaction	MAPRE1 interactions	LIMA1 NUP107 SPTAN1 SPTBN1 TAOK2 ALMS1 EIF4B CEP135 MACF1 KIF2A CTNNA1 CAPRIN1 NIN	2.41e-04	514	160	13	int:MAPRE1
Interaction	ECT2 interactions	LIMA1 ILF3 TCOF1 SPTAN1 SPTBN1 BIVM CEP164 BLM SART1 RNF123 SUPT16H CEP135 MACF1 UTP20 SMN1 PLOD1 CAPRIN1 RAB5C	2.47e-04	887	160	18	int:ECT2
Interaction	H3-4 interactions	ERAP1 SPTA1 NAP1L4 CASQ2 RBM39 TGM2 TNRC6A KMT2A SMN1 KIF2A DNAH5 PRDM16	2.50e-04	448	160	12	int:H3-4
Interaction	TBC1D17 interactions	TBC1D25 GTF3C1 RAB5A RAB5B RAB5C	2.53e-04	71	160	5	int:TBC1D17
Interaction	SNPH interactions	OBSL1 XPA KIF2A	2.55e-04	16	160	3	int:SNPH
Interaction	GNAT3 interactions	RNF123 SYNE2 RAB5C	2.55e-04	16	160	3	int:GNAT3
Interaction	ODF2 interactions	CEP164 NRP1 ALMS1 CEP135 TNRC6A PLOD1 NIN	2.73e-04	158	160	7	int:ODF2
Interaction	MYO7A interactions	ADGRV1 RNF123 RIPOR1 CTNNA1	2.80e-04	40	160	4	int:MYO7A
Interaction	LARP4 interactions	ILF3 CALR SCYL1 OBSL1 RBM39 FBXO10 HELZ CAPRIN1	2.80e-04	210	160	8	int:LARP4
Interaction	GJD3 interactions	ABCC1 SYNE1 SPTAN1 SPTBN1 SCYL1 HMGCR ANKLE2 COG1 VANGL1 SYNE2 NECTIN2 STOM	2.82e-04	454	160	12	int:GJD3
Interaction	C6 interactions	SART3 APOA1 RNF123	3.67e-04	18	160	3	int:C6
Interaction	ZNF727 interactions	CALR RNF123	3.72e-04	4	160	2	int:ZNF727
Interaction	CTBP1 interactions	SART3 MARCHF10 HMGCR TXNRD2 KMT2A HELZ EEF1AKMT2 CTNNA1 KDF1 PRDM16 RAB5C	4.11e-04	406	160	11	int:CTBP1
Interaction	ITGB3 interactions	ILF3 SPTAN1 SPTBN1 TGM2 PTPRZ1 CAPRIN1 TP53BP1	4.25e-04	170	160	7	int:ITGB3
Interaction	H3C6 interactions	LIMA1 ILF3 TCOF1 SPTAN1 SPTBN1 SART1 EIF4B SUPT16H	4.58e-04	226	160	8	int:H3C6
Interaction	CLUAP1 interactions	IQGAP2 HMGCR BBS9 RBM39 SART1 GTF3C1 LTN1 KIF2A	4.58e-04	226	160	8	int:CLUAP1
Interaction	YWHAH interactions	ARHGAP32 LIMA1 ILF3 SPTAN1 SPTBN1 HECTD4 TBC1D25 DZIP1 LPIN3 ALMS1 EIF4B SYNE2 NECTIN2 CEP135 KMT2A FNIP1 MACF1 KIF2A HERC1 NIN	4.72e-04	1102	160	20	int:YWHAH
GeneFamily	EF-hand domain containing\|Spectrins	SPTA1 SPTAN1 SPTBN1	6.36e-06	7	104	3	1113
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE1 SYNE2	1.95e-04	4	104	2	1252
GeneFamily	EF-hand domain containing\|Plakins	EVPL MACF1	8.97e-04	8	104	2	939
GeneFamily	Components of oligomeric golgi complex	COG7 COG1	8.97e-04	8	104	2	493
GeneFamily	WD repeat domain containing\|Xeroderma pigmentosum complementation groups\|Nucleotide excision repair	ERCC5 XPA	8.97e-04	8	104	2	1125
GeneFamily	Tudor domain containing	PHF20L1 SMN1 TP53BP1	1.25e-03	37	104	3	780
GeneFamily	ATP binding cassette subfamily C	ABCC3 ABCC1	2.45e-03	13	104	2	807
GeneFamily	Immunoglobulin like domain containing	FLT4 NRCAM OBSL1 PTK7 NECTIN2	5.16e-03	193	104	5	594
GeneFamily	RAB, member RAS oncogene GTPases	RAB5A RAB5B RAB5C	6.24e-03	65	104	3	388
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRH PTPRZ1	6.41e-03	21	104	2	813
GeneFamily	Apolipoproteins	APOA1 APOB	6.41e-03	21	104	2	405
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000	NBEAL1 COG7 RBM39 SYNE2 FNIP1 HERC1 PRDM16 MYBL1	3.82e-07	90	159	8	gudmap_developingGonad_P2_epididymis_1000_k4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000	NBEAL1 COG7 RBM39 SYNE2 FNIP1 HERC1 MYBL1	8.45e-06	97	159	7	gudmap_developingGonad_e18.5_epididymis_1000_k4
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500	RBM44 COG7 SPTBN1 RBM39 SYNE2 TAF7L FNIP1 DMRTA1 HERC1 KDF1 PRDM16 MYBL1	3.64e-05	387	159	12	gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_500	RBM44 RBM39 TAF7L DMRTA1	4.64e-05	27	159	4	gudmap_developingGonad_P2_testes_500_k4
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000	RBM44 NBEAL1 COG7 RBM39 SYNE2 FNIP1 DMRTA1 HERC1 MYBL1	6.75e-05	233	159	9	gudmap_developingGonad_e12.5_ovary_k5_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	RBM44 PDE7A NBEAL1 COG7 SPTBN1 RBM39 ALMS1 SYNE2 TAF7L FNIP1 DMRTA1 MPHOSPH8 ZCCHC7 HERC1 KDF1 MYBL1 MAJIN	7.50e-05	776	159	17	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000	RBM44 COG7 RBM39 SYNE2 FNIP1 HERC1 MYBL1	8.25e-05	138	159	7	gudmap_developingGonad_e12.5_epididymis_k5_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_200	RBM44 RBM39 TAF7L FNIP1 DMRTA1 MYBL1 MAJIN	1.28e-04	148	159	7	gudmap_developingGonad_e14.5_ ovary_200
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500	RBM39 SYNE2 FNIP1 HERC1 MYBL1	1.47e-04	67	159	5	gudmap_developingGonad_e18.5_epididymis_500_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000	ILF3 IQGAP2 VWA8 BIVM OBSL1 RBM39 CEP164 VCAN KIF2A	1.60e-04	261	159	9	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	SART3 ARHGAP32 ACAT2 GRIK4 CEP164 MFN1 ALMS1 COG1 PTPRZ1 SYNE2 SUPT16H CEP135 FNIP1 DMRTA1 MPHOSPH8 KIF2A MYBL1	1.71e-04	831	159	17	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#1_top-relative-expression-ranked_1000	RBM44 RBM39 TAF7L DMRTA1	2.47e-04	41	159	4	gudmap_developingGonad_P2_testes_1000_k1
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	RBM44 NBEAL1 COG7 SPTBN1 OBSL1 RBM39 SYNE2 TAF7L TNRC6A FNIP1 DMRTA1 ZCCHC7 HERC1 KDF1 PRDM16 MYBL1	2.52e-04	778	159	16	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_1000	FLT4 PPP1R12B MFN1 TAOK2 TGM2 LTN1 FNIP1 STOM	2.60e-04	220	159	8	gudmap_kidney_adult_RenMedVasc_Tie2_k4_1000
ToppCell	RSV-Healthy-0\|RSV / Virus stimulation, Condition and Cluster	LIMA1 PDE4A CALR ABCA10 FBXO10 VANGL1 SYNE2 KDF1 CTSW MYBL1	1.18e-09	180	161	10	974044056e2f7e909cb11c6f6ca89e58bf95f7e5
ToppCell	RSV-Healthy-0\|Healthy / Virus stimulation, Condition and Cluster	LIMA1 PDE4A CALR ABCA10 FBXO10 VANGL1 SYNE2 KDF1 CTSW MYBL1	1.18e-09	180	161	10	703a1d0f9536af94d56757eb01221878d7b7fe61
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FLT4 SYNE1 GTF3C1 SYNE2 HELZ MACF1 KIF2A CTSW STOM MYBL1	3.10e-09	199	161	10	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HOPX SYNE1 RBM39 DDHD1 SYNE2 KMT2A MACF1 KIF2A CTSW MYBL1	3.26e-09	200	161	10	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CALR HOPX SYNE1 RBM39 SYNE2 KMT2A MACF1 KIF2A CTSW MYBL1	3.26e-09	200	161	10	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	FLT4 HOPX SYNE1 GTF3C1 SYNE2 KIF2A CTSW STOM MYBL1	1.59e-08	175	161	9	cc2428150987911d0d382e8177918724aa69f85c
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	FLT4 HOPX SYNE1 BIVM GTF3C1 SYNE2 KIF2A CTSW MYBL1	1.67e-08	176	161	9	003076f1a983409ddf31b9c19e61c1facdd72566
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMH+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	IQGAP2 CALR HOPX SYNE1 VANGL1 SYNE2 MACF1 CTSW MYBL1	2.58e-08	185	161	9	097d628f92e13250c15b550f2fd1f4225fc07558
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	HOPX SYNE1 SPTAN1 SPTBN1 SYNE2 KMT2A MACF1 CTSW MYBL1	4.43e-08	197	161	9	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	mild-Lymphocytic-NK_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CALR HOPX SYNE1 GRIK4 SYNE2 MACF1 CTSW STOM MYBL1	4.63e-08	198	161	9	dce3c008757786aa6bd4a869456b76b4cbbb1d5b
ToppCell	T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	IQGAP2 HOPX SYNE1 SYNE2 KMT2A MACF1 CTSW STOM MYBL1	4.63e-08	198	161	9	1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HOPX SYNE1 SPTAN1 SPTBN1 SYNE2 KMT2A MACF1 CTSW MYBL1	4.83e-08	199	161	9	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	severe-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CALR HOPX SYNE1 RBM39 GTF3C1 SYNE2 KIF2A CTSW MYBL1	5.04e-08	200	161	9	2253d74049cc49c92e897ff4aa298d913daeb739
ToppCell	severe-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CALR HOPX SYNE1 RBM39 GTF3C1 SYNE2 KIF2A CTSW MYBL1	5.04e-08	200	161	9	6aa77955017d073a96324e4db6b9950a2ec46cf8
ToppCell	Leuk-UTI-Lymphocyte-T_NK-gdT\|Leuk-UTI / Disease, Lineage and Cell Type	HOPX SYNE1 DZIP1 GTF3C1 SYNE2 PRDM16 CTSW MYBL1	1.15e-07	158	161	8	c4b0af25608cee3d0d2b0193f5ff45d9dc87078b
ToppCell	normal-na-Lymphocytic_NK-NK_dim-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 GRIK4 RBM39 SYNE2 CTSW MYBL1	3.85e-07	185	161	8	b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IQGAP2 HOPX SYNE1 IRF6 GTF3C1 SYNE2 CTSW MYBL1	4.18e-07	187	161	8	6981b856187a2e689260ecb7d0a1193a374ee9b9
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 GTF3C1 SYNE2 CTSW STOM MYBL1	4.91e-07	191	161	8	b2d0ea24970da09209da9d9dda76e30fbfe22917
ToppCell	COPD-Lymphoid\|COPD / Disease state, Lineage and Cell class	PDE7A IQGAP2 HOPX SYNE1 NAP1L4 SYNE2 CTSW MYBL1	5.11e-07	192	161	8	064fefb8212fadab0ff441f4bf643559b7fdb25d
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 GTF3C1 SYNE2 CTSW STOM MYBL1	5.11e-07	192	161	8	01d01c9293f2439dc4c34c648273319c9beee5c7
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 GTF3C1 SYNE2 CTSW STOM MYBL1	5.11e-07	192	161	8	0f8c63de26128694f4522f9f6d029e4628c890bc
ToppCell	ASK452-Immune-NK_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	ACD HOPX SYNE1 ADGRV1 MIA2 SYNE2 CTSW MYBL1	5.11e-07	192	161	8	f04ee5aaa54c39b7493098fb3d2f78168d6b8060
ToppCell	control-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	IQGAP2 HOPX SYNE1 DDHD1 KMT2A CTSW STOM MYBL1	5.31e-07	193	161	8	89d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	PDE4A HOPX SYNE1 RBM39 GTF3C1 SYNE2 CTSW MYBL1	5.31e-07	193	161	8	e790ab76c12f74a13936c231076f1e397283efb3
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMH+-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 GTF3C1 SYNE2 CTSW STOM MYBL1	5.31e-07	193	161	8	3184a5f454e3ac5a81f6bacf9bd8f07d9d448fba
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMH+\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 GTF3C1 SYNE2 CTSW STOM MYBL1	5.31e-07	193	161	8	123d4d13c8944c32bf4a5d7fdc65e3b65aa568ef
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	IQGAP2 HOPX SYNE1 GTF3C1 SYNE2 CTSW STOM MYBL1	5.53e-07	194	161	8	ecdfc27d06e363fb23f0309f26ef6404a89f14ec
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	PDE4A HOPX SYNE1 RBM39 GTF3C1 SYNE2 CTSW MYBL1	5.53e-07	194	161	8	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IQGAP2 SYNE1 SPTAN1 NAP1L4 SYNE2 KIF2A CTSW MYBL1	5.97e-07	196	161	8	e4c76e7ad68455e51fe93ce588bcec9383f8654b
ToppCell	Healthy/Control-gd_T\|World / Disease group and Cell class	CALR HOPX SYNE1 RBM39 GTF3C1 SYNE2 CTSW MYBL1	5.97e-07	196	161	8	b982c84552e7efbff2be861f0f569f40804f5d88
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 GTF3C1 SYNE2 CTSW STOM MYBL1	6.20e-07	197	161	8	76304df40f87224f8e415677e3ee8fb183fe0c03
ToppCell	10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8\|blood / Manually curated celltypes from each tissue	CALR HOPX SYNE1 GTF3C1 SYNE2 CTSW STOM MYBL1	6.20e-07	197	161	8	13e6611cde9364f0c1bf681b0b26c4d2725e5f4a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	IQGAP2 HOPX SYNE1 NAP1L4 GTF3C1 SYNE2 CTSW MYBL1	6.20e-07	197	161	8	32b770e403028862f91e4727f4a8fbb6151910e4
ToppCell	mild-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SPTAN1 NAP1L4 THOC3 DDHD1 SYNE2 KMT2A MPHOSPH8 KIF2A	6.20e-07	197	161	8	39800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCell	T_cells-CTLs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	IQGAP2 HOPX SYNE1 SYNE2 MACF1 PRDM16 CTSW MYBL1	6.20e-07	197	161	8	2de34e20915a247bee75aa40495e23c20bb23e18
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HOPX SYNE1 RBM39 SYNE2 MACF1 KIF2A CTSW MYBL1	6.45e-07	198	161	8	34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe
ToppCell	mild-Lymphocytic-CD8_T_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CALR HOPX SYNE1 SYNE2 MACF1 CTSW STOM MYBL1	6.45e-07	198	161	8	629a1229759f3088cafb36f27a3d19d7249aab3a
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	FLT4 HOPX SPTAN1 SPTBN1 NRP1 TGFB2 MACF1 CTNNA1	6.70e-07	199	161	8	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	mild-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SPTAN1 NAP1L4 THOC3 SYNE2 KMT2A MACF1 MPHOSPH8 KIF2A	6.70e-07	199	161	8	06c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.70e-07	199	161	8	4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.70e-07	199	161	8	eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.70e-07	199	161	8	10c8729b779073c3bf808e85958d59147f0be5c5
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.70e-07	199	161	8	867fd292f3879982422e840e087bfdb3b21a8715
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.70e-07	199	161	8	5e9fe852a70546c9d235414a2c26ca3e67ba6eb9
ToppCell	Control-Lymphoid_T/NK-NK\|Control / Disease group, lineage and cell class	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.70e-07	199	161	8	94b2693a8378b9b2c58c6aebb2c6658d75b2e3de
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.70e-07	199	161	8	d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPTAN1 SPTBN1 NRP1 TAOK2 SYNE2 KMT2A MACF1 NIN	6.95e-07	200	161	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	mild-gd_T\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CALR HOPX SYNE1 SYNE2 KIF2A CTSW STOM MYBL1	6.95e-07	200	161	8	2c21ede46a42b8e2f8e99ecca365baa52056eb17
ToppCell	severe-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FLT4 HOPX GTF3C1 SYNE2 KMT2A KIF2A CTSW MYBL1	6.95e-07	200	161	8	8a849d0ef244aa2666da2d31bd0731fb04e40911
ToppCell	mild-MAIT\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FLT4 HOPX GTF3C1 SYNE2 KIF2A CTSW STOM MYBL1	6.95e-07	200	161	8	1e3ef15ce48b9a19a6ac3e08ea0234a9376e6596
ToppCell	Control-Control-Lymphocyte-T/NK-NK\|Control / Disease, condition lineage and cell class	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.95e-07	200	161	8	c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCell	Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD4+_CTL\|ICU-NoSEP / Disease, condition lineage and cell class	HOPX SYNE1 SPTAN1 ULK3 SYNE2 MACF1 CTSW MYBL1	6.95e-07	200	161	8	c470520ce77130811fdc2a1d3d796d8836275de1
ToppCell	healthy_donor\|World / Disease condition, Lineage, Cell class and subclass	HOPX SYNE1 RBM39 EIF4B SYNE2 MACF1 CTSW MYBL1	6.95e-07	200	161	8	afd4d5609adaa470e3d880f8be4a4d55e162b3d6
ToppCell	severe-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CALR HOPX SYNE1 RBM39 GTF3C1 SYNE2 CTSW MYBL1	6.95e-07	200	161	8	d6767f06fe13be8110a86c2a6029be2dd9ce666c
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	ABCC1 PDE7A RBM39 SYNE2 MACF1 DMRTA1 HERC1	1.64e-06	156	161	7	1545169694f686d28648a68b552c2ae606599d66
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC1 PDE4A IQGAP2 APOA1 GRIK4 RASSF5 TMEM266	3.14e-06	172	161	7	3a37569a5902f3c65ff8d3912421309a8c82ee9b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	IQGAP2 HOPX SYNE1 SYNE2 CTSW STOM MYBL1	3.14e-06	172	161	7	86f52f486d67217fc1b8443ab362c975df2974a4
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC1 PDE4A IQGAP2 APOA1 GRIK4 RASSF5 TMEM266	3.14e-06	172	161	7	cc9d9dae290f11f8c348c78228af4e49469dc93b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	IQGAP2 HOPX SYNE1 SYNE2 CTSW STOM MYBL1	3.14e-06	172	161	7	fb2df8fea6df5947165f13978f1d1006d15b60fd
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	IQGAP2 HOPX SYNE1 SYNE2 CTSW STOM MYBL1	3.14e-06	172	161	7	e38ebb216e4ddcd008148fcbaf709b4f3c83706a
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	SYNE1 PPP1R12B SPTAN1 GRIK4 KMT2A HERC1 USP47	3.79e-06	177	161	7	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	normal-na-Lymphocytic_NK-T_mait-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	FLT4 HOPX GTF3C1 SYNE2 MACF1 CTSW MYBL1	4.24e-06	180	161	7	e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78
ToppCell	lymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell\|World / Lineage, cell class and subclass	HOPX GRIK4 GTF3C1 PRDM16 CTSW STOM MYBL1	4.39e-06	181	161	7	0d096d7d557fd2e71b35e41816e11d7e83cd9210
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW MYBL1	4.72e-06	183	161	7	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IQGAP2 HOPX SYNE1 IRF6 GTF3C1 CTSW MYBL1	5.26e-06	186	161	7	fc0b488c201a32d829047b58460297df2818b45d
ToppCell	mild_COVID-19_(asymptomatic)-gd_T\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	HOPX SYNE1 GTF3C1 SYNE2 TMEM266 CTSW MYBL1	5.26e-06	186	161	7	5fa3ed834898aa06aae15a8ade7ab93a6e4744f8
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLT4 HOPX GTF3C1 SYNE2 CTSW STOM MYBL1	5.44e-06	187	161	7	f1ba41f2ec703251a81c46e08d45e70210f298e7
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RBM39 DDHD1 SYNE2 KMT2A MACF1 HERC1 TP53BP1	5.64e-06	188	161	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COPD-Lymphoid-NK\|COPD / Disease state, Lineage and Cell class	IQGAP2 HOPX SYNE1 GRIK4 SYNE2 CTSW MYBL1	5.64e-06	188	161	7	c9a227c8e71b69929d43e9afb8306a95c8163778
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 RBM39 GTF3C1 CTSW MYBL1	5.64e-06	188	161	7	a29c43a91ed1364a09d5abab6efa51b8061bce74
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NRCAM IRF6 ADGRV1 GJB1 PTPRZ1 UCN3 PRDM16	5.84e-06	189	161	7	5d9da836ce4308b8458bb3be3871a0aca734b6cd
ToppCell	COPD-Lymphoid-NK\|World / Disease state, Lineage and Cell class	IQGAP2 HOPX SYNE1 GRIK4 SYNE2 CTSW MYBL1	5.84e-06	189	161	7	c0ac160fa7e68b92414fb1600abcac8ad1a42232
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPTAN1 NAP1L4 THOC3 SYNE2 KIF2A CTSW MYBL1	5.84e-06	189	161	7	5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	HOPX SYNE1 RBM39 DDHD1 SYNE2 CTSW MYBL1	5.84e-06	189	161	7	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	(1)_T_CD8_gd\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PDE4A HOPX NAP1L4 PRDM16 CTSW STOM MYBL1	5.84e-06	189	161	7	62eda4bcfd21d5025ac676d524994ede22721c1d
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT\|lymph-node_spleen / Manually curated celltypes from each tissue	FLT4 HOPX GTF3C1 SYNE2 CTSW STOM MYBL1	5.84e-06	189	161	7	afe3a4fe7c10eeeb7064129778d940269c9acbef
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ABCC3 HOPX EVPL IRF6 ADGRV1 DNAH5 PRDM16	6.25e-06	191	161	7	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE4A IQGAP2 HOPX PRDM16 CTSW STOM MYBL1	6.25e-06	191	161	7	f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMK+-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HOPX SYNE1 SYNE2 KIF2A CTSW STOM MYBL1	6.25e-06	191	161	7	2ad34ccd55362db04511c90cf264ae5b93b48dde
ToppCell	(210)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	HOPX GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.47e-06	192	161	7	08dc0c019c594da7b9944db8fd706aa7780e6ae9
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NRCAM IRF6 ADGRV1 PTPRZ1 BUB1B PRDM16 MYBL1	6.47e-06	192	161	7	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE4A IQGAP2 HOPX PRDM16 CTSW STOM MYBL1	6.47e-06	192	161	7	4d72b9264ed62e0c08cde4078061b348253f6989
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMK+\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HOPX SYNE1 SYNE2 KIF2A CTSW STOM MYBL1	6.47e-06	192	161	7	7460ce6e2f91bbf940b684f63231db7501ace09f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW MYBL1	6.47e-06	192	161	7	ce867b6e78c1d8f30dff81bf572a78a897bc7625
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HOPX SYNE1 GTF3C1 SYNE2 MACF1 CTSW MYBL1	6.47e-06	192	161	7	58a7829b411b02b422ef75e2277a868969cc23e8
ToppCell	(21)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	HOPX GTF3C1 SYNE2 MACF1 CTSW STOM MYBL1	6.47e-06	192	161	7	b0a573ddde2978485a857b8261ee1ee5ef68ecef
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 SYNE2 MACF1 KIF2A CTSW STOM MYBL1	6.47e-06	192	161	7	ed1fb700d3e8f00495727d61e164fc0b70274fd0
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 SYNE2 MACF1 KIF2A CTSW STOM MYBL1	6.47e-06	192	161	7	6779b0294bb058e748e22b795b6a381c4add37e9
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 SYNE2 CTSW STOM MYBL1	6.69e-06	193	161	7	d66cbb8c71bdc57faecb74a16fe3f34cb0b33228
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 SYNE2 CTSW STOM MYBL1	6.69e-06	193	161	7	c1d9c2436503791350086a503d6b98c5c69f44ae
ToppCell	3'_v3-Lung-Lymphocytic_NK\|Lung / Manually curated celltypes from each tissue	HOPX SYNE1 RBM39 GTF3C1 SYNE2 CTSW MYBL1	6.69e-06	193	161	7	a98ee519e0da93ae4a2dcdda1ee8b4138dec131b
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NRCAM APOA1 IRF6 ADGRV1 GJB1 PTPRZ1 PRDM16	6.69e-06	193	161	7	4b8202fcfe639a73f69a13f48fc3601ade256346
ToppCell	BLOOD--(1)_EM_CTLs\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HOPX SYNE1 GTF3C1 SYNE2 CTSW STOM MYBL1	6.92e-06	194	161	7	66583c6cff3814902d6babdea3a2ae962decde65
ToppCell	3'_v3-Lung-Lymphocytic_NK-NK_CD16\|Lung / Manually curated celltypes from each tissue	HOPX SYNE1 RBM39 GTF3C1 SYNE2 CTSW MYBL1	6.92e-06	194	161	7	3337042eef91a49f621058785723228cf4dfdad4
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HOPX APOA1 IRF6 ADGRV1 ESRP2 GJB1 PTPRZ1	6.92e-06	194	161	7	acd5ba9a097595d4caab4f05440531c65a4aa7bc
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE4A IQGAP2 HOPX VANGL1 HELZ CTSW MYBL1	6.92e-06	194	161	7	8a596f25f6bfa5baaa2f52d80ad92f2925713398
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CALR HOPX SYNE1 SYNE2 CTSW STOM MYBL1	6.92e-06	194	161	7	95ab357d5f7bf91ba287417928c8575e655814fc
ToppCell	IIF-Lymphocyte-T_NK-NK\|IIF / Disease, Lineage and Cell Type	CALR HOPX GRIK4 RBM39 GTF3C1 CTSW MYBL1	7.16e-06	195	161	7	464ce05cb52f78aee22d3baa6641b37bd53aae16
ToppCell	3'_v3-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	HOPX SYNE1 RBM39 GTF3C1 SYNE2 CTSW MYBL1	7.16e-06	195	161	7	789149fb52d9d16393e1649358515add60d37f2d
ToppCell	BLOOD--(1)_T_cell-(1)_EM_CTLs\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HOPX SYNE1 GTF3C1 PLOD1 CTSW STOM MYBL1	7.16e-06	195	161	7	7df67ad5c62235474ee56ea07a957253d45f066b
Drug	platinum	ABCC3 ABCC1 ERCC5 XPA ZNF77 BLM SLC22A16 VCAN BUB1B SUPT16H	6.67e-07	183	159	10	CID000023939
Drug	plakin	SYNE1 SPTA1 SPTAN1 SPTBN1 EVPL SYNE2 MACF1	1.74e-06	82	159	7	CID000018752
Drug	Advicor	APOA1 APOB SYNE2	3.31e-06	5	159	3	CID000151176
Drug	Crilvastatine	APOA1 APOB HMGCR	3.31e-06	5	159	3	CID000060724
Drug	Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; PC3; HT_HG-U133A	FLT4 ILF3 ERAP1 SPTBN1 BBS9 TGFB2 MIA2 PTPRH VCAN	6.92e-06	187	159	9	4581_UP
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A	NRCAM ERAP1 SPTBN1 GNB1L IRF6 TGFB2 VCAN CEP135 KIF2A	1.10e-05	198	159	9	6238_UP
Drug	niacin	RTL5 APOA1 APOB HMGCR TGFB2 VCAN SYNE2 SUPT16H DNAH5	1.10e-05	198	159	9	CID000000937
Disease	Colorectal Carcinoma	ABCC3 ABCC1 NRCAM TCOF1 CALR SYNE1 APOB ABCA10 MFN1 ARHGEF10L TGM2 BUB1B DMRTA1 KDF1 RAB5C	5.61e-06	702	157	15	C0009402
Disease	post-operative acute kidney injury	ZNF215 ARHGEF10L CAPRIN1	1.21e-05	9	157	3	EFO_0009955
Disease	white matter hyperintensity measurement	ABCC1 NRCAM NBEAL1 EVPL RASSF5 MICB VCAN KIF2A PRDM16	3.69e-05	302	157	9	EFO_0005665
Disease	platelet component distribution width	FLT4 IQGAP2 SYNE1 SPTA1 NAP1L4 RIPOR3 MIA2 PTPRH DDHD1 MACF1 EEF1AKMT2 KIF2A HERC1 PRDM16	5.49e-05	755	157	14	EFO_0007984
Disease	Ataxia with vitamin E deficiency	APOA1 APOB	8.41e-05	3	157	2	C1848533
Disease	concentration of large LDL particles measurement	APOB HMGCR ABCA10 NECTIN2	8.87e-05	44	157	4	EFO_0022160
Disease	cholesterol in medium VLDL measurement	APOB HMGCR ABCA10 NECTIN2	8.87e-05	44	157	4	EFO_0022225
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	HECTD4 APOB HMGCR SYNE2 NECTIN2 MACF1 KDF1 TP53BP1	8.95e-05	264	157	8	EFO_0008317, EFO_0020944
Disease	metabolic syndrome	HECTD4 APOB HMGCR TAOK2 TNRC6A KMT2A DMRTA1	1.02e-04	200	157	7	EFO_0000195
Disease	mean platelet volume	ARHGAP32 IQGAP2 ERAP1 SPTA1 SPTBN1 RASSF5 DDHD1 SYNE2 MCM9 NECTIN2 TNRC6A RIPOR1 KIF2A PRDM16 TBX6 NIN	1.15e-04	1020	157	16	EFO_0004584
Disease	free cholesterol in small VLDL measurement	APOB HMGCR ABCA10 NECTIN2	1.15e-04	47	157	4	EFO_0022272
Disease	free cholesterol in medium VLDL measurement	APOB HMGCR ABCA10 NECTIN2	1.15e-04	47	157	4	EFO_0022269
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	APOB HMGCR SYNE2 NECTIN2 MACF1 TP53BP1	1.26e-04	144	157	6	EFO_0004611, EFO_0020943
Disease	cholesteryl esters to total lipids in IDL percentage	APOB NECTIN2 MACF1 TP53BP1	1.47e-04	50	157	4	EFO_0022247
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	APOB HMGCR SYNE2 NECTIN2 MACF1 TP53BP1	1.57e-04	150	157	6	EFO_0004611, EFO_0020947
Disease	phospholipids in very small VLDL measurement	APOB HMGCR ABCA10 TP53BP1	1.59e-04	51	157	4	EFO_0022300
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	1.68e-04	4	157	2	cv:CN293514
Disease	phospholipids in IDL measurement	APOB HMGCR ABCA10 NECTIN2	1.71e-04	52	157	4	EFO_0022164
Disease	total lipids in LDL measurement	APOA1 APOB HMGCR NECTIN2	1.71e-04	52	157	4	EFO_0022308
Disease	cholesterol in small VLDL measurement	APOB HMGCR ABCA10 NECTIN2	1.84e-04	53	157	4	EFO_0022228
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	APOB HMGCR SYNE2 NECTIN2 MACF1 KDF1 TP53BP1	1.95e-04	222	157	7	EFO_0008317, EFO_0020943
Disease	Malignant neoplasm of breast	ABCC1 NRCAM SYNE1 PPP1R12B SPTAN1 GNB1L TGM2 MIA2 KCNT2 OTOGL SYNE2 NECTIN2 MACF1 UTP20 PLOD1 TP53BP1	2.06e-04	1074	157	16	C0006142
Disease	cortical surface area measurement, neuroimaging measurement	SPTBN1 BBS9 NRP1 VCAN TNRC6A EEF1AKMT2 DMRTA1	2.23e-04	227	157	7	EFO_0004346, EFO_0010736
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	APOB SYNE2 NECTIN2 MACF1 TP53BP1	2.30e-04	103	157	5	EFO_0008595, EFO_0020944
Disease	total lipids in large LDL	APOA1 APOB HMGCR NECTIN2	2.45e-04	57	157	4	EFO_0022163
Disease	cholesterol in large LDL measurement	APOA1 APOB HMGCR NECTIN2	2.45e-04	57	157	4	EFO_0021901
Disease	Behcet Syndrome	ERAP1 APOA1 APOB	2.76e-04	24	157	3	C0004943
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	2.78e-04	5	157	2	C1450051
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE1 SYNE2	2.78e-04	5	157	2	C0410190
Disease	scoliosis (implicated_via_orthology)	PTK7 TBX6	2.78e-04	5	157	2	DOID:0060249 (implicated_via_orthology)
Disease	sexual dimorphism measurement	LIMA1 APOA1 APOB HMGCR MON1A RBM39 CEP164 TAOK2 TGFB2 SART1 NECTIN2 TNRC6A FNIP1 MACF1 HERC1 TP53BP1	2.86e-04	1106	157	16	EFO_0021796
Disease	cholesterol to total lipids in IDL percentage	APOB NECTIN2 MACF1 TP53BP1	2.98e-04	60	157	4	EFO_0022233
Disease	Ciliopathies	NPHP1 ADGRV1 BBS9 CEP164 DNAH5	3.12e-04	110	157	5	C4277690
Disease	free cholesterol in VLDL measurement	APOB HMGCR NECTIN2 TP53BP1	3.18e-04	61	157	4	EFO_0022276
Disease	cystatin C measurement	PDE7A HECTD4 ADGRV1 ULK3 RNF123 ALMS1 NECTIN2 TMEM266 FNIP1	3.18e-04	402	157	9	EFO_0004617
Disease	free cholesterol measurement	APOA1 APOB HMGCR ABCA10 NECTIN2	3.54e-04	113	157	5	EFO_0008591
Disease	carcinoma (implicated_via_orthology)	FLT4 RAB5A RAB5B RAB5C	3.82e-04	64	157	4	DOID:305 (implicated_via_orthology)
Disease	Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	4.16e-04	6	157	2	cv:C0410189
Disease	glucagon measurement, glucose tolerance test	MACF1 HERC1	4.16e-04	6	157	2	EFO_0004307, EFO_0008463
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE1 SYNE2	4.16e-04	6	157	2	C0410189
Disease	cholesteryl ester measurement	APOA1 APOB HMGCR ABCA10 NECTIN2 KDF1 TP53BP1	4.71e-04	257	157	7	EFO_0010351
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	APOB SYNE2 NECTIN2 MACF1 TP53BP1	4.84e-04	121	157	5	EFO_0008595, EFO_0020943
Disease	fatty acid measurement	HOPX APOB HMGCR NECTIN2 KMT2A MACF1 KDF1 TP53BP1 KLB	5.71e-04	436	157	9	EFO_0005110
Disease	glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement	GBA2 SYNE2	5.80e-04	7	157	2	EFO_0800551
Disease	gallbladder cancer (is_marker_for)	CALR BUB1B	5.80e-04	7	157	2	DOID:3121 (is_marker_for)
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	5.80e-04	7	157	2	C0751337
Disease	platelet crit	PDE4A IQGAP2 ERAP1 APOB HMGCR ADGRV1 MFN1 LPIN3 PTPRH MICB NECTIN2 DMRTA1 PLOD1 PRDM16	5.90e-04	952	157	14	EFO_0007985
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	APOB SYNE2 NECTIN2 MACF1 TP53BP1	6.04e-04	127	157	5	EFO_0008595, EFO_0020947
Disease	complex trait	APOA1 APOB HMGCR TAOK2 NECTIN2 TNRC6A MACF1	6.45e-04	271	157	7	EFO_0010578
Disease	coffee consumption	NRCAM HECTD4 ULK3	6.54e-04	32	157	3	EFO_0004330
Disease	free cholesterol to total lipids in large LDL percentage	APOB NECTIN2 MACF1 TP53BP1	6.64e-04	74	157	4	EFO_0022280
Disease	free cholesterol to total lipids in small VLDL percentage	APOB HMGCR NECTIN2 TP53BP1	6.99e-04	75	157	4	EFO_0022287
Disease	fatty liver disease (biomarker_via_orthology)	ABCC3 APOA1 APOB	7.17e-04	33	157	3	DOID:9452 (biomarker_via_orthology)
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	APOB SYNE2 NECTIN2 MACF1 KDF1 TP53BP1	7.28e-04	200	157	6	EFO_0004611, EFO_0020945
Disease	Colorectal Neoplasms	ABCC3 ABCC1 NRCAM CALR SYNE1 ABCA10 BUB1B	7.34e-04	277	157	7	C0009404
Disease	brain measurement, neuroimaging measurement	DCHS2 SPTBN1 GBA2 BBS9 NRP1 VCAN TNRC6A MACF1 DMRTA1 PRDM16	7.59e-04	550	157	10	EFO_0004346, EFO_0004464
Disease	myelofibrosis (is_implicated_in)	CALR KMT2A	7.71e-04	8	157	2	DOID:4971 (is_implicated_in)
Disease	premature menopause (biomarker_via_orthology)	ACAT2 HMGCR	7.71e-04	8	157	2	DOID:10787 (biomarker_via_orthology)
Disease	2-aminooctanoate measurement	ALMS1 TMEM266	7.71e-04	8	157	2	EFO_0800349
Disease	obsolete_red blood cell distribution width	TSR2 ABCC1 SPTA1 HECTD4 APOB MON1A THOC3 GBA2 BBS9 RNF123 PTPRH SLC22A16 COG1 SYNE2 DMRTA1 HERC1 USP47	8.66e-04	1347	157	17	EFO_0005192
Disease	Xeroderma pigmentosum	ERCC5 XPA	9.88e-04	9	157	2	cv:C0043346
Disease	Hypercholesterolemia	APOA1 APOB HMGCR	1.17e-03	39	157	3	C0020443
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DNHD1 FLT4 TGM2 GJB1 SYNE2	1.20e-03	148	157	5	C0279702
Disease	intermediate density lipoprotein measurement	APOB HMGCR ABCA10 NECTIN2	1.22e-03	87	157	4	EFO_0008595
Disease	2-ketocaprylate measurement	ALMS1 TMEM266	1.23e-03	10	157	2	EFO_0800110
Disease	familial hypercholesterolemia (is_implicated_in)	APOA1 APOB	1.23e-03	10	157	2	DOID:13810 (is_implicated_in)
Disease	cholesterol in very small VLDL measurement	APOB HMGCR ABCA10	1.26e-03	40	157	3	EFO_0022231
Disease	free cholesterol in medium LDL measurement	APOB HMGCR NECTIN2	1.26e-03	40	157	3	EFO_0022268
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	APOB HMGCR SYNE2 MACF1 KDF1 TP53BP1	1.31e-03	224	157	6	EFO_0004530, EFO_0008317
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	APOB HMGCR NECTIN2 MACF1 KDF1 TP53BP1	1.34e-03	225	157	6	EFO_0008317, EFO_0020947
Disease	reticulocyte count	IQGAP2 VWA8 HOPX SPTA1 HECTD4 NRP1 RASSF5 PTPRH SLC22A16 SYNE2 LTN1 DMRTA1 HERC1 TBX6	1.44e-03	1045	157	14	EFO_0007986
Disease	Basal cell carcinoma	ERCC5 XPA	1.50e-03	11	157	2	C0007117
Disease	spleen volume	SPTA1 HECTD4 DMRTA1	1.56e-03	43	157	3	EFO_0600047
Disease	subiculum volume	SPTBN1 VCAN EEF1AKMT2	1.56e-03	43	157	3	EFO_0009399
Disease	triglycerides in large LDL measurement	APOB SYNE2 TP53BP1	1.56e-03	43	157	3	EFO_0022319
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB HMGCR TP53BP1	1.56e-03	43	157	3	EFO_0022290
Disease	total lipids in very small VLDL measurement	APOB HMGCR ABCA10	1.78e-03	45	157	3	EFO_0022156
Disease	Renal dysplasia and retinal aplasia (disorder)	NPHP1 CEP164	1.79e-03	12	157	2	C0403553
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	SYNE1 SYNE2	1.79e-03	12	157	2	DOID:11726 (implicated_via_orthology)
Disease	N-acetyl-2-aminooctanoate measurement	ALMS1 TMEM266	1.79e-03	12	157	2	EFO_0800567
Disease	alcohol consumption measurement, alcohol drinking	HECTD4 KLB	1.79e-03	12	157	2	EFO_0004329, EFO_0007878
Disease	total lipids in small LDL	APOB HMGCR NECTIN2	2.02e-03	47	157	3	EFO_0022168
Disease	free cholesterol in very small VLDL measurement	APOB HMGCR ABCA10	2.02e-03	47	157	3	EFO_0022275
Disease	physical activity measurement	ILF3 MARCHF10 ERAP1 NECTIN2 DMRTA1 HERC1	2.05e-03	245	157	6	EFO_0008002
Disease	gastroesophageal reflux disease	APOB MON1A VCAN RAB5B	2.11e-03	101	157	4	EFO_0003948
Disease	Bardet-Biedl Syndrome	NPHP1 ALMS1	2.11e-03	13	157	2	C0752166
Disease	Hyperlipoproteinemia Type IIb	APOB HMGCR	2.11e-03	13	157	2	C1704417
Disease	cortical surface area measurement	DCHS2 IQGAP2 NBEAL1 PPP1R12B SPTBN1 HMGCR ADGRV1 CNTLN BBS9 NRP1 VCAN TNRC6A MACF1 EEF1AKMT2 DMRTA1 TBX6	2.24e-03	1345	157	16	EFO_0010736
Disease	phospholipids in medium LDL measurement	APOB HMGCR NECTIN2	2.28e-03	49	157	3	EFO_0022183
Disease	apolipoprotein B to apolipoprotein A1 ratio	APOB HMGCR NECTIN2	2.28e-03	49	157	3	EFO_0021897
Disease	cholesterol in medium LDL measurement	APOB HMGCR NECTIN2	2.28e-03	49	157	3	EFO_0022224
Disease	cholesterol in small LDL measurement	APOB HMGCR NECTIN2	2.28e-03	49	157	3	EFO_0022227
Disease	triglycerides to total lipids in medium LDL percentage	APOB NECTIN2 TP53BP1	2.41e-03	50	157	3	EFO_0022334
Disease	free cholesterol in LDL measurement	APOB HMGCR NECTIN2	2.41e-03	50	157	3	EFO_0022266
Disease	Bardet-Biedl syndrome (is_implicated_in)	NPHP1 BBS9	2.45e-03	14	157	2	DOID:1935 (is_implicated_in)
Disease	free cholesterol in large LDL measurement	APOB HMGCR NECTIN2	2.55e-03	51	157	3	EFO_0022176
Disease	triglycerides to total lipids in large LDL percentage	APOB NECTIN2 TP53BP1	2.55e-03	51	157	3	EFO_0022331
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	APOB NECTIN2 TP53BP1	2.55e-03	51	157	3	EFO_0022302
Disease	remnant cholesterol measurement	APOB HMGCR ABCA10 NECTIN2	2.69e-03	108	157	4	EFO_0010815
Disease	total lipids in medium LDL	APOB HMGCR NECTIN2	2.70e-03	52	157	3	EFO_0022180

Protein segments in the cluster

Peptide	Gene	Start	Entry
STRTEEVQDDNWGET	VANGL1	61	Q8TAA9
EVQDDNWGETTTAIT	VANGL1	66	Q8TAA9
SLEGDEWELSKENVQ	BUB1B	16	O60566
SKENFWDGITDESID	ERICH6B	326	Q5W0A0
WDGITDESIDKLEVE	ERICH6B	331	Q5W0A0
SSRVAEWDSTEKIGD	ARHGEF10L	381	Q9HCE6
EWDSTEKIGDLFVAS	ARHGEF10L	386	Q9HCE6
AVEKGEEDTFSDLIW	ANKLE2	316	Q86XL3
QEADKWSTLSADIEE	COG7	126	P83436
TDSWDGVVEDKQTQE	VCAN	471	P13611
VFENLSKDGWEDVSE	CNTLN	856	Q9NXG0
ELGNVDDKIDTTVEW	ABCA10	1521	Q8WWZ4
WIDENKIATTGEANE	ADAM2	231	Q99965
SEDGDAILWETELEK	FBXO10	696	Q9UK96
GISNLTWAVEEEDFE	ADGRV1	5281	Q8WXG9
EAKLEENSDVTSWSE	ALMS1	3916	Q8TCU4
ENSDVTSWSEEKREE	ALMS1	3921	Q8TCU4
WEIDKSEFDGVTTNS	BIVM	141	Q86UB2
LELWSDENKISTVGE	ADAM32	236	Q8TC27
VTQEFWDNLEKETEG	APOA1	91	P02647
WEVVDKDSGTFILSD	DNHD1	1196	Q96M86
EETPVSWKDDTERTN	CBWD5	341	Q5RIA9
TSGEKEQVDEWTVET	CAPRIN1	306	Q14444
WDLAEGEEQDSLDTS	NWD1	1241	Q149M9
DSKEVVHATEGLDWE	NXPH2	21	O95156
LEKSDDDTWIERGQV	NBEAL1	1456	Q6ZS30
TEEEVGWDTEIKDDV	RBM39	436	Q14498
TSEDWSDAKESLTGV	RBM44	781	Q6ZP01
SFVLKENETGEVEWD	RASSF5	356	Q8WWW0
DTTVKFEIWDTAGQE	RAB5A	66	P20339
DTTVKFEIWDTAGQE	RAB5B	66	P61020
DDTTVKFEIWDTAGQ	RAB5C	66	P51148
DWLESIAKDEIGEFS	NUP107	271	P57740
DIQDEGWETLEVSSA	GDF2	196	Q9UK05
LEDSWTALEGAEDKE	ABCC3	861	O15438
GEWKTEDEASLEDAL	P4HA3	216	Q7Z4N8
VSSEGEKIEGWELTT	LTN1	556	O94822
GTDVTTELDSWIDKF	MFN1	181	Q8IWA4
ELSQALADVTWEKDG	OBSL1	1651	O75147
SEWHSENEEEEKLAG	NAP1L4	121	Q99733
WDDKVVISDIDGTIT	LPIN3	636	Q9BQK8
GLEVSDVSKWEESVL	TRIT1	346	Q9H3H1
EDGSVVLWDVSEQKV	GNB1L	186	Q9BYB4
ASDITDVQKQDSEWG	MAJIN	116	Q3KP22
SQDVELWEGEVVKEL	LIMA1	726	Q9UHB6
VEEDTFKSVSWNDDG	HSFX4	91	A0A1B0GTS1
GDDEWTSVVVANVSK	NRCAM	791	Q92823
DSAEVKAWLETSEGF	HMGCR	601	P04035
GSTSAKVQWDEAEIT	HERC1	2341	Q15751
EETPVSWKDDTERTN	CBWD2	341	Q8IUF1
EETPVSWKDDTERTN	CBWD1	341	Q9BRT8
IDKQTWTDEGSVSER	ERAP1	711	Q9NZ08
GVEEALDATIAWEAS	PDE4A	741	P27815
WKGLQREQSSSEDTD	PDE7A	451	Q13946
LQELECDWEEVTTSG	EVPL	1716	Q92817
AFEEEKWDEISIGSL	MOCOS	786	Q96EN8
VLGAKTWDTETEDLT	MICB	76	Q29980
TWDTETEDLTENGQD	MICB	81	Q29980
SVEEWEDTKDSKEQG	KCNT2	976	Q6UVM3
IAAEAGLSEEETQKW	HOPX	36	Q9BPY8
ESKAWAVLTSDEESG	PTPRZ1	1536	P23471
ESEDSEEWKGHLAQA	DMP1	26	Q13316
EWEKEEGGSTEAVHS	HECTD4	1336	Q9Y4D8
KEASWDVAEQPTTAD	ARHGAP32	1276	A7KAX9
VEEDTFKSVSWNDDG	HSFX3	91	A0A1B0GWH4
RADWKLTSSAEDEVE	HELZ	1556	P42694
EDTQELGWEETVDAA	BBS9	761	Q3SYG4
SLLDDWASKGTLVEE	MACF1	4371	Q9UPN3
KLVAEWEGQDSDSDQ	PLOD1	166	Q02809
VARVSVSDADGDWEK	DCHS2	436	Q6V1P9
DVSSNGEDWITIKEG	NRP1	361	O14786
NESVTVEWIENGDTK	KIF2A	36	O00139
TTEGDEEDATEAWRL	MON1A	236	Q86VX9
EDWEVKAHQAEGESS	CEP135	891	Q66GS9
EEKIEFEWNTGTNVD	APOB	1171	P04114
ETQIKVNWEEEAASG	APOB	4051	P04114
TEEQKDDSEWLSSDV	BLM	221	P54132
WDELEIQEEAESGSS	COG1	716	Q8WTW3
EVSKWDDSGNDIIVL	CTNNA1	701	P35221
DKSSVQSDEVWVGVV	GBA2	811	Q9HCG7
ESGLESTEETWQSEK	FNIP1	696	Q8TF40
KEELLNEFSEGWSTV	EEF1AKMT2	196	Q5JPI9
SSSDLESGNESEWVK	DMRTA1	296	Q5VZB9
ESGNESEWVKDLTAT	DMRTA1	301	Q5VZB9
SDWIDEQEKGSSEQA	ILF3	46	Q12906
VKSEEGIWAETVSSQ	CTSW	301	P56202
EETPVSWKDDTERTN	CBWD3	341	Q5JTY5
EETPVSWKDDTERTN	CBWD6	341	Q4V339
IDNSQVESGSLEDDW	CALR	186	P27797
LVVAAESVWGDEKSS	GJB1	36	P08034
TEEETQSEECLWVGV	MARCHF10	291	Q8NA82
ENGWFTDSRVKTEDT	KLB	416	Q86Z14
WSAEVFEDDDGSLKN	KMT2A	1906	Q03164
WIEDVLSGKINTEDD	CASQ2	361	O14958
EWRSKLTLDGDTVDS	DDHD1	456	Q8NEL9
EESLEWEKTTNSSEP	GRIK4	941	Q16099
EGSLEDWDIAVQKTE	SART3	556	Q15020
SLVLDNWEKEESGTQ	MYBL1	626	P10243
NWEKEESGTQLLTED	MYBL1	631	P10243
EGVILDLEKTWEESD	DNAH5	4026	Q8TE73
EEKEENESHKWSTGE	NPHP1	141	O15259
RGLWSTDSAEEDKET	MPHOSPH8	396	Q99549
EDIGLFIESWEIEKS	OTOGL	1706	Q3ZCN5
ADETDDLEGDVSTTW	EIF4B	41	P23588
EKEVDVLESWLDFTG	PHF20L1	966	A8MW92
EEENTIFKAWAVETG	IRF6	51	O14896
DIGSTSESKDWEEVV	MIA2	186	Q96PC5
LEGSDLWSLNKEDTS	ABCC1	236	P33527
TVTAVKDSGEWNLEA	MCM9	386	Q9NXL9
TGEAKDWAISVTQEG	RTL5	196	Q5HYW3
VSTRWEVIAEDGTKE	TAF7L	276	Q5H9L4
EKSVGDESWEQTQEG	UTP20	781	O75691
EWSEGAKSQEDTEAV	UTP6	446	Q9NYH9
VTEGAWRKTEAEEEE	SUSD5	376	O60279
LQSEVWDSEEGAEAT	TBC1D25	671	Q3MII6
DVIWEDSASENQEGL	RNASEH2A	251	O75792
DQEKILEDAVDEWTG	SYNE1	5201	Q8NF91
GVSATSTWLDDVEER	SYNE1	6386	Q8NF91
EAESSEGSWEKLQEV	SYNE2	5326	Q8WXH0
TSGHWETQEEDKDTA	SCYL1	621	Q96KG9
AQVGKWEEDSESSSE	TCOF1	536	Q13428
EREGLQSSAWTEEKV	NIN	741	Q8N4C6
WEEAAKLESENESKS	SLC22A16	536	Q86VW1
LGDSESVSKVLWLDE	IQGAP2	506	Q13576
AKETDFGWEQILTDV	PRDM16	121	Q9HAZ2
DQTSGTITDDSDIWL	ERCC5	801	P28715
QETGLSQEWSSVEED	SMIM17	61	P0DL12
SLWGKEDESLLDEEF	TAOK2	871	Q9UL54
GQSDDSDIWDDTALI	SMN1	26	Q16637
TDATEDDFGVWEVKT	ESRP2	191	Q9H6T0
EDSTEGTAEANWAKE	KDF1	116	Q8NAX2
SKESLGSEEESGKDW	SUPT16H	976	Q9Y5B9
DWDISSLEEEISLGK	DZIP1	791	Q86YF9
STLDDATDAWGIKVE	STOM	176	P27105
SDAATIAEWKDGLNE	SPTBN1	1771	Q01082
VTREALDTSDWEEKE	ACD	71	Q96AP0
LESSLWEEASDEGTL	CEP164	1196	Q9UPV0
KIWDEDEESTDTSEI	ARMCX1	36	Q9P291
DAVEEGDWTATVVDQ	TGM2	81	P21980
KTRAEGEWLSFDVTD	TGFB2	191	P61812
AQTIKEEDIVEDGWT	TSR2	171	Q969E8
SNDEEIVKFTGSDSW	ZNF77	66	Q15935
GEQTWPTEEELSEAK	TSR1	366	Q2NL82
SVGDWEVTAESQEAL	ZSCAN20	216	P17040
SEDIGSKLDSWEEHI	MIXL1	211	Q9H2W2
TKAGWSLEDVDIFEI	ACAT2	306	Q9BWD1
LKGRIESDDSQTWDE	RIPOR3	236	Q96MK2
RIEKATDGSLQSEDW	TOM1	16	O60784
VSVEDWEKGANTSTT	RNF123	1296	Q5XPI4
WINEKEAALTSEEVG	SPTAN1	1106	Q13813
IESLDTWTEFVEGKN	FLT4	501	P35916
NKGVAVSWETEETLE	FAM170A	136	A1A519
DIAEVETGDKLWEVQ	THOC3	291	Q96J01
GKKETWDTAEEDSGT	USP47	1001	Q96K76
KTGWDTSESELSEGE	PRPF40B	841	Q6NWY9
ENRELWKEFSSVGTE	TBX6	96	O95947
LEWIGDKEAIATSVE	SPTA1	171	P02549
DKEAIATSVELGEDW	SPTA1	176	P02549
EGVEKCSDSQSWEDI	TP53BP1	776	Q12888
EENIGWSTVNLDEEK	SART1	601	O43290
LEVWGSQEALEEAKE	XPA	191	P23025
QLQVTWEDSTTGKED	TXNRD2	291	Q9NNW7
EDKVLTWSGQEEVVS	UEVLD	351	Q8IX04
VTEGEDGINWSISDK	ZCCHC7	201	Q8N3Z6
VEFSKEEWGQLDSAV	ZNF215	171	Q9UL58
SEAEKGQWEDASLLS	UCN3	41	Q969E3
ETDTDWDIKSEQSDL	THAP10	231	Q9P2Z0
SQDGVTWEAEVELAT	GTF3C1	861	Q12789
DTDALLAEWDKSGVV	VWA8	1486	A3KMH1
EGSGKQVWDSEETIF	RIPOR1	246	Q6ZS17
SVWVEKDGVNSSVEI	PTPRH	276	Q9HD43
EAILEGDFSTKSDVW	PTK7	976	Q13308
WKSTEEEDQGSATSQ	TNRC6A	641	Q8NDV7
VLEAGTWDEETAAES	TMEM266	296	Q2M3C6
WEADTLDKEGLSESV	ULK3	451	Q6PHR2
DGSEEVKETWHERLS	PPP1R12B	821	O60237
DWEAKETQVSGTLAG	NECTIN2	201	Q92692